Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Oncopeptides
Oncopeptides
FDA Rescinds Approval of Oncopeptides' Blood Cancer Treatment: Implications and What's Next
Medriva
Mon, 02/26/24 - 10:44 am
Oncopeptides
Pepaxto
FDA
Multiple Myeloma
FDA looks to pull approval for Oncopeptides' troubled multiple myeloma drug Pepaxto
Fierce Pharma
Thu, 12/8/22 - 10:01 am
Oncopeptides
Multiple Myeloma
Pepaxto
FDA
Oncopeptides Sees Redemption with Positive Multiple Myeloma Data after ODAC Vote
BioSpace
Wed, 10/26/22 - 06:40 pm
Oncopeptides
clinical trials
Pepaxto
relapsed or refractory multiple myeloma
FDA advisory committee issues back to back negative votes on two cancer drugs
MedCity News
Mon, 09/26/22 - 10:31 am
FDA
Spectrum Pharmaceuticals
Oncopeptides
clinical trials
poziotinib
Pepaxto
Multiple Myeloma
Despite being approved in Europe, Oncopeptides' Pepaxto will remain sidelined in the US
Fierce Pharma
Sun, 09/25/22 - 02:00 pm
FDA
Oncopeptides
Multiple Myeloma
Pepaxto
FDA slams Spectrum and Oncopeptides cancer drugs over efficacy concerns ahead of ODAC meeting
Endpoints
Tue, 09/20/22 - 08:40 pm
FDA
oncology
Spectrum Pharmaceuticals
Oncopeptides
poziotinib
Pepaxto
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
FDA
Bristol Myers Squibb
deucravacitinib
Amylyx Pharmaceuticals
ALS
AMX0035
Ferring Pharmaceuticals
microbiome
RBX2660
Revance Therapeutics
Bluebird Bio
Spectrum Pharmaceuticals
JNJ
Oncopeptides
Months after pulling only drug from US, Oncopeptides takes back withdrawal request — but stays mum on why
Endpoints
Mon, 01/24/22 - 10:16 am
Oncopeptides
FDA
Pepaxto
Multiple Myeloma
Oncopeptides' shares crash as it pulls Pepaxto from the market, plans to shut down commercial units
Fierce Pharma
Sun, 10/24/21 - 10:28 pm
Oncopeptides
Pepaxto
FDA alert renews concerns about Oncopeptides’ Pepaxto
BioWorld
Wed, 07/28/21 - 11:17 pm
Oncopeptides
Multiple Myeloma
Peptaxo
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides' multiple myeloma drug
Fierce Biotech
Thu, 07/8/21 - 11:06 am
Oncopeptides
melflufen
clinical trials
FDA
clinical hold
Multiple Myeloma